全文获取类型
收费全文 | 43611篇 |
免费 | 3237篇 |
国内免费 | 154篇 |
专业分类
耳鼻咽喉 | 332篇 |
儿科学 | 1386篇 |
妇产科学 | 1231篇 |
基础医学 | 5414篇 |
口腔科学 | 744篇 |
临床医学 | 6647篇 |
内科学 | 8446篇 |
皮肤病学 | 608篇 |
神经病学 | 4377篇 |
特种医学 | 1209篇 |
外科学 | 4558篇 |
综合类 | 451篇 |
一般理论 | 70篇 |
预防医学 | 4993篇 |
眼科学 | 640篇 |
药学 | 2491篇 |
中国医学 | 59篇 |
肿瘤学 | 3346篇 |
出版年
2023年 | 329篇 |
2022年 | 426篇 |
2021年 | 984篇 |
2020年 | 790篇 |
2019年 | 1161篇 |
2018年 | 1260篇 |
2017年 | 964篇 |
2016年 | 1155篇 |
2015年 | 1210篇 |
2014年 | 1579篇 |
2013年 | 2287篇 |
2012年 | 3377篇 |
2011年 | 3365篇 |
2010年 | 1820篇 |
2009年 | 1604篇 |
2008年 | 2946篇 |
2007年 | 3041篇 |
2006年 | 2905篇 |
2005年 | 2827篇 |
2004年 | 2585篇 |
2003年 | 2404篇 |
2002年 | 2242篇 |
2001年 | 335篇 |
2000年 | 275篇 |
1999年 | 333篇 |
1998年 | 531篇 |
1997年 | 354篇 |
1996年 | 365篇 |
1995年 | 320篇 |
1994年 | 275篇 |
1993年 | 276篇 |
1992年 | 189篇 |
1991年 | 155篇 |
1990年 | 142篇 |
1989年 | 154篇 |
1988年 | 138篇 |
1987年 | 105篇 |
1986年 | 121篇 |
1985年 | 153篇 |
1984年 | 122篇 |
1983年 | 139篇 |
1982年 | 151篇 |
1981年 | 154篇 |
1980年 | 147篇 |
1979年 | 62篇 |
1978年 | 65篇 |
1977年 | 63篇 |
1976年 | 68篇 |
1975年 | 57篇 |
1974年 | 52篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Marike Gabrielson Mattias Hammarström Magnus Bäcklund Jenny Bergqvist Kristina Lång Ann H Rosendahl Signe Borgquist Roxanna Hellgren Kamila Czene Per Hall 《International journal of cancer. Journal international du cancer》2023,152(11):2362-2372
Tamoxifen prevents recurrence of breast cancer and is suggested for preventive risk-reducing therapy. Tamoxifen reduces mammographic density, a proxy for therapy response, but little is known about its effects in remodelling normal breast tissue. Our study, a substudy within the double-blinded dose-determination trial KARISMA, investigated tamoxifen-specific changes in breast tissue composition and histological markers in healthy women. We included 83 healthy women randomised to 6 months daily intake of 20, 10, 5, 2.5, 1 mg of tamoxifen or placebo. The groups were combined to “no dose” (0-1 mg), “low-dose” (2.5-5 mg) or “high-dose” (10-20 mg) of tamoxifen. Ultrasound-guided biopsies were collected before and after tamoxifen exposure. In each biopsy, epithelial, stromal and adipose tissues was quantified, and expression of epithelial and stromal Ki67, oestrogen receptor (ER) and progesterone receptor (PR) analysed. Mammographic density using STRATUS was measured at baseline and end-of-tamoxifen-exposure. We found that different doses of tamoxifen reduced mammographic density and glandular-epithelial area in premenopausal women and associated with reduced epithelium and increased adipose tissue. High-dose tamoxifen also decreased epithelial ER and PR expressions in premenopausal women. Premenopausal women with the greatest reduction in proliferation also had the greatest epithelial reduction. In postmenopausal women, high-dose tamoxifen decreased the epithelial area with no measurable density decrease. Tamoxifen at both low and high doses influences breast tissue composition and expression of histological markers in the normal breast. Our findings connect epithelial proliferation with tissue remodelling in premenopausal women and provide novel insights to understanding biological mechanisms of primary prevention with tamoxifen. 相似文献
2.
Jasmine Poonian Nicola Walsham Thomas Kilner Elizabeth Bradbury Kristen Brooks Emma West 《Emergency medicine Australasia : EMA》2020,32(4):700-702
Emergency Medicine staff in Australia and New Zealand are at the forefront of the healthcare response to COVID‐19. This article describes a well‐being plan for ED staff that has been devised to mitigate against the negative psychological impact of the COVID‐19 pandemic. 相似文献
3.
4.
Factors predicting the development of pressure ulcers in an at‐risk population who receive standardized preventive care: secondary analyses of a multicentre randomised controlled trial
下载免费PDF全文
![点击此处可从《Journal of advanced nursing》网站下载免费的PDF全文](/ch/ext_images/free.gif)
5.
6.
7.
8.
9.
10.
Nicola Flaum Emma J. Crosbie Richard J. Edmondson Miriam J. Smith Dafydd G. Evans 《Clinical genetics》2020,97(1):54-63
Ovarian cancer is the fourth most common cause of cancer-related death in women in the developed world, and one of the most heritable cancers. One of the most significant risk factors for epithelial ovarian cancer (EOC) is a family history of breast and/or ovarian cancer. Combined risk factors can be used in models to stratify risk of EOC, and aid in decisions regarding risk-reduction strategies. Germline pathogenic variants in EOC susceptibility genes including those involved in homologous recombination and mismatch repair pathways are present in approximately 22% to 25% of EOC. These genes are associated with an estimated lifetime risk of EOC of 13% to 60% for BRCA1 variants and 10% to 25% for BRCA2 variants, with lower risks associated with remaining genes. Genome-wide association studies have identified single nucleotide polymorphisms (SNPs) thought to explain an additional 6.4% of the familial risk of ovarian cancer, with 34 susceptibility loci identified to date. However, an unknown proportion of the genetic component of EOC risk remains unexplained. This review comprises an overview of individual genes and SNPs suspected to contribute to risk of EOC, and discusses use of a polygenic risk score to predict individual cancer risk more accurately. 相似文献